000			02261 a2200601 4500
005			20250516105706.0
264		0	_c20130211
008			201302s 0 0 eng d
022			_a1549-490X
024	7		_a10.1634/theoncologist.2011-0467 _2doi
040			_aNLM _beng _cNLM
100	1		_aPautier, Patricia
245	0	0	_aRandomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). _h[electronic resource]
260			_bThe oncologist _c2012
300			_a1213-20 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDisease-Free Survival
650	0	4	_aDocetaxel
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFrance _xepidemiology
650	0	4	_aGranulocyte Colony-Stimulating Factor _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aLeiomyosarcoma _xdrug therapy
650	0	4	_aLenograstim
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aTaxoids _xtherapeutic use
650	0	4	_aUterine Neoplasms _xdrug therapy
650	0	4	_aGemcitabine
700	1		_aFloquet, Anne
700	1		_aPenel, Nicolas
700	1		_aPiperno-Neumann, Sophie
700	1		_aIsambert, Nicolas
700	1		_aRey, Annie
700	1		_aBompas, Emmanuelle
700	1		_aCioffi, Angela
700	1		_aDelcambre, Corinne
700	1		_aCupissol, Didier
700	1		_aCollin, Françoise
700	1		_aBlay, Jean-Yves
700	1		_aJimenez, Marta
700	1		_aDuffaud, Florence
773	0		_tThe oncologist _gvol. 17 _gno. 9 _gp. 1213-20
856	4	0	_uhttps://doi.org/10.1634/theoncologist.2011-0467 _zAvailable from publisher's website
999			_c22039055 _d22039055